|
Alectinib
- 英文名称:Alectinib
- 品牌:WYTSCI
- 产地:进口
- 型号:1MG
- 货号:WT-AY-B11410
- cas:1256580-46-7
- 价格: ¥1/mg
- 发布日期: 2025-04-10
- 更新日期: 2025-11-03
产品详请
| 产地 | 进口 |
| 品牌 | WYTSCI |
| 货号 | WT-AY-B11410 |
| 用途 | 科研检测 |
| 英文名称 | Alectinib |
| 包装规格 | 1MG |
| CAS编号 | 1256580-46-7 |
| 别名 | Alectinib |
| 纯度 | 98+% |
| 分子式 | |
| 是否进口 | 是 |
纯度:99% by HPLC;NMR (Conforms)
分子式:C30H34N4O2
分子量:482.62
溶剂:DMSO (5 mg/ml)
性状:White solid
存储:-20°C
Activity (short version):ALK inhibitor
Function / Pharmacology:Alectinib is a potent (IC50 = 1.9 nM) and highly selective ALK inhibitor.1 It blocked phosphorylation of both native ALK and the L1196M, C1156Y, and F1174L mutants. Alectinib has also been shown to inhibit RET kinase (IC50 = 4.8 nM), the RET gatekeeper mutations V804L and V804M, and inhibited the growth of RET fusion positive cells.2 Alectinib is clinically useful in the treatment of ALK-positive Non-Small Cell Lung Cancer. It effectively suppressed cell proliferation and induced apoptosis in a mouse neuroblastoma xenograft.3
分子式:C30H34N4O2
分子量:482.62
溶剂:DMSO (5 mg/ml)
性状:White solid
存储:-20°C
Activity (short version):ALK inhibitor
Function / Pharmacology:Alectinib is a potent (IC50 = 1.9 nM) and highly selective ALK inhibitor.1 It blocked phosphorylation of both native ALK and the L1196M, C1156Y, and F1174L mutants. Alectinib has also been shown to inhibit RET kinase (IC50 = 4.8 nM), the RET gatekeeper mutations V804L and V804M, and inhibited the growth of RET fusion positive cells.2 Alectinib is clinically useful in the treatment of ALK-positive Non-Small Cell Lung Cancer. It effectively suppressed cell proliferation and induced apoptosis in a mouse neuroblastoma xenograft.3



